89bio Inc (NASDAQ:ETNB) currently has a daily average trading volume of 2.03M but it saw 2568206 shares traded in last market. With a market cap of 1.41B USD, the company’s current market price of $9.65 came rising about 0.42 while comparing to the previous closing price of $9.61. In past 52 weeks, the stock remained buoying in the range of price level as high as $11.84 and as low as $4.16.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Goldman which initiated the stock as “Neutral” in its note to investors issued on March 14, 2025, recommending a price target of $11 for it.
Over the week, ETNB’s stock price is moving 26.31% up while it is 45.77% when we observe its performance for the past one month. Year-to-date it is 23.40% up and over the past year, the stock is showing an upside performance of 7.94%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.46 while estimate for next year EPS is -2.08.
Currently, 89bio Inc’s total number of outstanding shares is 145.98M with 0.63% of that held by the insiders while 108.82% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -60.20% and return on equity (ROE) at -69.30%. Stock’s beta reads 1.50. Stock has a price to book (P/B) ratio of 2.33. Its return on asset (ROA) is -61.26% on average.
